http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SI-21100-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2001-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b66d979ba1f78125a7d37858ce48ccd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51b671ab428c2f3eb75c9857a818c3e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e801054d5e3f8c8512ef30a409dd817e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b594bf327a62f13d358d81191155045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76f835861a8f6025adb733a5e0f270cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77bb4eac547a9ea554302544d53d9ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c32622518c0e02dc4557c23b9e4bbb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d346ad825bc8f384a3c4e77cd003c390
publicationDate 2009-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SI-21100-B
titleOfInvention Polymorph of the epothilone analog
abstract According to the present invention, two crystalline polymorphs of the epothilone analog represented by Formula (I) are named Form A and Form B and mixtures thereof are given. In addition, methods for making new polymorphs, therapeutic methods for their use, and pharmaceutical dosage forms containing said polymorphs are provided.
priorityDate 2000-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078

Total number of triples: 36.